ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed
Sweet Ping Ng
Matched on ORCID iD 0000-0003-1721-0680; OpenAlex author ID A5052290457. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper
Papers 5
- Stereotactic radiotherapy and the potential role of magnetic resonance-guided adaptive techniques for pancreatic cancer. Last author DOI 10.3748/wjg.v28.i7.745↗
- Setup Management for Stereotactic Body Radiation Therapy of Patients With Pancreatic Cancer Treated via the Breath-Hold Technique. Co-author DOI 10.1016/j.prro.2019.10.012↗
- Current and emerging radiotherapy strategies for pancreatic adenocarcinoma: stereotactic, intensity modulated and particle radiotherapy. Co-author DOI 10.21037/apc.2018.07.03↗
- Stereotactic Radiotherapy and Particle Therapy for Pancreatic Cancer. Co-author DOI 10.3390/cancers10030075↗
- SBRT for Unresectable Pancreatic Cancer Can Improve Local Control With Minimal Toxicity. Co-author DOI 10.1016/j.ijrobp.2017.05.034↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Joseph M. Herman · 3 shared papers, 2017–2020 · strength 0.46
- Paper Stereotactic Radiotherapy and Particle Therapy for Pancreatic Cancer. DOI 10.3390/cancers10030075↗
- Paper SBRT for Unresectable Pancreatic Cancer Can Improve Local Control With Minimal Toxicity. DOI 10.1016/j.ijrobp.2017.05.034↗
- Paper Setup Management for Stereotactic Body Radiation Therapy of Patients With Pancreatic Cancer Treated via the Breath-Hold… DOI 10.1016/j.prro.2019.10.012↗
- Vijayaragavan Muralidharan · 1 shared paper, 2022 · strength 0.17
- Tai Ermongkonchai · 1 shared paper, 2022 · strength 0.17
- Niall Christopher Tebbutt · 1 shared paper, 2022 · strength 0.17
- Eugene Jon Koay · 1 shared paper, 2018 · strength 0.17
- Roland Teboh Forbang · 1 shared paper, 2020 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.